A Pharmaceutical giant, Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial.
Trending
- Niger Legislators confused over lack of defined roles for Humanitarian Ministry and NSEMA
- Explainer: Why children are more vulnerable to drowning
- Commissioner urged to address delays in road projects across Niger State
- Cyclone Chido death toll in Mozambique rises to 73
- Family of Late Emir of Borgu renew calls for justice over use of family land
- FG committed to end AIDS by 2030 – NACA DG
- Yobe gov spends N15.3bn on grains, others in 1 year
- Stakeholders harp on safe alternatives to GMOs in Nigeria
